Alphatec reports $24.4M in Q2 2017 revenue: 9 highlights Featured

Written by  Megan Wood | Friday, 11 August 2017 16:32
Social sharing

Alphatec reported its second quarter 2017 financial results.

Here are nine highlights from the second quarter of 2017:


1. The company reported total revenue of $24.4 million.


2. U.S. commercial business total revenue was $21.9 million.


3. The company's total operating expenses were $16.5 million, a decrease of $3.7 million from the first quarter of 2017.


4. Alphatec's cash balance was $19.1 million, as of June 30.


5. The company saw an operating loss of $0.7 million, reflecting a sequential improvement from $3.4 million in the first quarter.


6. Non-GAAP adjusted EBITDA was $1.2 million.


7. Alphatec reported a U.S. commercial gross margin of 71 percent.


8. As of June 30, the company's cash and cash equivalents were $19.1 million.


9. The sales from dedicated sales agents and distributors increased to more than 18 percent of U.S. commercial revenue.


In the second quarter, Alphatec received a patent for its uniplanar and monoaxial screws within its arsenal deformity line. The company also received a patent protecting the Alphatec Squadron Lateral Retractor.


More articles on devices:
Tissue Regenix acquires CellRight Technologies in $30M deal: 6 things to know
Study: Are physical exams of SI joint accurate for diagnoses?
Lane Hale named President & CEO of ECA Medical Instruments

© Copyright ASC COMMUNICATIONS 2017. Interested in LINKING to or REPRINTING this content? View our policies here.

Top 40 Articles from the Past 6 Months